日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775

乐伐替尼联合帕博利珠单抗治疗既往接受过治疗的晚期子宫内膜癌：随机、3期研究309/KEYNOTE-775的5年结果

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013713
Makker, Vicky; Colombo, Nicoletta; Casado, Antonio; Santin, Alessandro D; Colomba, Emeline; Miller, David S; Fujiwara, Keiichi; Pignata, Sandro; Yonemori, Kan; Kim, Yong Man; Baron-Hay, Sally; Ray-Coquard, Isabelle; Shapira-Frommer, Ronnie; Kristeleit, Rebecca; Nishio, Shin; Suzuki, Shiro; Guerra Alía, Eva M; Sanli, Ulus A; Selle, Frederic; Shikama, Ayumi; Martínez Rodríguez, Jorge L; Arik, Zafer; Arican, Ali; Sebastianelli, Alexandra; Yu, Zhou; McKenzie, Jodi; Kruger, Stephan; Meng, Robin; Okpara, Chinyere E; Lorusso, Domenica
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Real-world data-based assessment of therapy-related myeloid neoplasms after poly(ADP-ribose) polymerase inhibitor treatment in ovarian cancer

基于真实世界数据的卵巢癌患者接受聚（ADP-核糖）聚合酶抑制剂治疗后治疗相关髓系肿瘤的评估

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2026.1728766
Uekusa, Ryosuke; Yokoi, Akira; Watanabe, Eri; Inoue, Mikako; Mizuno, Katsuhiko; Yoshida, Kosuke; Yoshikawa, Nobuhisa; Niimi, Kaoru; Suzuki, Shiro; Kajiyama, Hiroaki
肿瘤
肿瘤免疫
卵巢癌
发表日期：2026
文献求助 收藏

The rice BRITTLE CULM 4 gene encodes a membrane protein affecting cellulose synthesis in the secondary cell wall

水稻脆茎4基因编码一种膜蛋白，该蛋白影响次生细胞壁中纤维素的合成。

期刊:Plant and Cell Physiology
影响因子:4
doi:10.1093/pcp/pcaf096
Yamaguchi, Masatoshi; Sato, Ami; Takahashi, Daisuke; Mori, Kazuhisa; Fujimoto, Ryota; Miyagi, Atsuko; Sato, Eriko; Ishikawa, Toshiki; Sano, Ryosuke; Kurata, Tetsuya; Suzuki, Shiro; Kaneko, Yasuko; Kawai-Yamada, Maki; Kotake, Toshihisa
细胞生物学
发表日期：2025
文献求助 收藏

Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study

日本女性子宫浆液性癌的诊断准确性和预后因素：一项多中心研究

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2025.36.e93
Nishio, Shin; Ushijima, Kimio; Ishikawa, Mitsuya; Tokunaga, Hideki; Horie, Koji; Yamaguchi, Satoshi; Suzuki, Shiro; Yahata, Hideaki; Tsuda, Hitoshi; Satoh, Toyomi
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Enzymatic characterization and docking simulation of a xylan synthase catalytic subunit, Setaria viridis IRX10, using xylotrimer acceptors with distinct fluorescent labels

利用带有不同荧光标记的木聚糖三聚体受体，对狗尾草（Setaria viridis）木聚糖合酶催化亚基IRX10进行酶学表征和分子对接模拟。

期刊:Plant Biotechnology
影响因子:1.1
doi:10.5511/plantbiotechnology.25.0123a
Suzuki, Seichi; Kizuka, Yasuhiko; Mikami, Bunzo; Yamauchi, Kosei; Ishimizu, Takeshi; Suzuki, Shiro
信号转导
IF
发表日期：2025
文献求助 收藏

Discovering cancer stem-like molecule, nuclear factor I X, using spatial transcriptome in gastric cancer

利用胃癌空间转录组发现癌症干细胞样分子——核因子 IX

期刊:Cancer Science
影响因子:4.5
doi:10.1111/cas.16288
Akira Ishikawa, Takafumi Fukui, Aya Kido, Narutaka Katsuya, Kazuya Kuraoka, Naohiro Uraoka, Takahisa Suzuki, Shiro Oka, Takahiro Kotachi, Hassan Ashktorab, Duane Smoot, Wataru Yasui
发育与干细胞
胃癌
干细胞
发表日期：2024
文献求助 收藏

Safety assessments and clinical features of PARP inhibitors from real-world data of Japanese patients with ovarian cancer

基于日本卵巢癌患者真实世界数据的PARP抑制剂安全性评估和临床特征

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-63600-z
Uekusa, Ryosuke; Yokoi, Akira; Watanabe, Eri; Yoshida, Kosuke; Yoshihara, Masato; Tamauchi, Satoshi; Shimizu, Yusuke; Ikeda, Yoshiki; Yoshikawa, Nobuhisa; Niimi, Kaoru; Suzuki, Shiro; Kajiyama, Hiroaki
PARP
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer

研究 309/KEYNOTE-775 中东亚亚组的分析：乐伐替尼联合帕博利珠单抗与医生选择的化疗方案治疗既往接受过治疗的晚期或复发性子宫内膜癌患者

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2024.35.e40
Yonemori, Kan; Fujiwara, Keiichi; Hasegawa, Kosei; Yunokawa, Mayu; Ushijima, Kimio; Suzuki, Shiro; Shikama, Ayumi; Minobe, Shinichiro; Usami, Tomoka; Kim, Jae-Weon; Kim, Byoung-Gie; Wang, Peng-Hui; Chang, Ting-Chang; Yamamoto, Keiko; Han, Shirong; McKenzie, Jodi; Orlowski, Robert J; Miura, Takuma; Makker, Vicky; Man Kim, Yong
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Proposal for Classifying the Emetogenicity of Oral Anticancer Agents with a Focus on PARP Inhibitors: A Prospective, Observational, Multicenter Study (JASCC-CINV 2002)

关于口服抗癌药物致吐性分类的提议，重点关注 PARP 抑制剂：一项前瞻性、观察性、多中心研究 (JASCC-CINV 2002)

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.91675
Yamamoto, Senri; Tsuchiya, Masami; Iihara, Hirotoshi; Hayasaki, Yoh; Hori, Kyoko; Kumakura, Yasuo; Watanabe, Daichi; Sakai, Hideki; Nakagawa, Satoshi; Kudoh, Akiko; Oishi, Hajime; Kado, Nobuhiro; Go, Makiko; Mashima, Kota; Uchida, Takashi; Yasue, Moeka; Maeda, Akimitsu; Nishino, Kimihiro; Matsumoto, Koji; Sato, Shinya; Ueda, Yutaka; Tomio, Kensuke; Hayashi, Katsuhisa; Takenaka, Motoki; Mori, Masahiko; Kajiyama, Hiroaki; Bomoto, Yoshimasa; Suzuki, Shiro; Ishihara, Takuma; Suzuki, Akio; Abe, Masakazu
ASC
PARP
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Real-world data of poly (ADP-ribose) polymerase inhibitor response in Japanese patients with ovarian cancer

日本卵巢癌患者对聚（ADP-核糖）聚合酶抑制剂反应的真实世界数据

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.7149
Uekusa, Ryosuke; Yokoi, Akira; Watanabe, Eri; Yoshida, Kosuke; Yoshihara, Masato; Tamauchi, Satoshi; Shimizu, Yusuke; Ikeda, Yoshiki; Yoshikawa, Nobuhisa; Niimi, Kaoru; Suzuki, Shiro; Kajiyama, Hiroaki
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏